These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 21150911

  • 1. Regulatory role of cannabinoid receptor 1 in stress-induced excitotoxicity and neuroinflammation.
    Zoppi S, Pérez Nievas BG, Madrigal JL, Manzanares J, Leza JC, García-Bueno B.
    Neuropsychopharmacology; 2011 Mar; 36(4):805-18. PubMed ID: 21150911
    [Abstract] [Full Text] [Related]

  • 2. Regulatory role of the cannabinoid CB2 receptor in stress-induced neuroinflammation in mice.
    Zoppi S, Madrigal JL, Caso JR, García-Gutiérrez MS, Manzanares J, Leza JC, García-Bueno B.
    Br J Pharmacol; 2014 Jun; 171(11):2814-26. PubMed ID: 24467609
    [Abstract] [Full Text] [Related]

  • 3. Systemic administration of oleoylethanolamide protects from neuroinflammation and anhedonia induced by LPS in rats.
    Sayd A, Antón M, Alén F, Caso JR, Pavón J, Leza JC, Rodríguez de Fonseca F, García-Bueno B, Orio L.
    Int J Neuropsychopharmacol; 2014 Dec 28; 18(6):. PubMed ID: 25548106
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological augmentation of endocannabinoid signaling reduces the neuroendocrine response to stress.
    Surkin PN, Gallino SL, Luce V, Correa F, Fernandez-Solari J, De Laurentiis A.
    Psychoneuroendocrinology; 2018 Jan 28; 87():131-140. PubMed ID: 29065362
    [Abstract] [Full Text] [Related]

  • 5. Evidence against a critical role of CB1 receptors in adaptation of the hypothalamic-pituitary-adrenal axis and other consequences of daily repeated stress.
    Rabasa C, Pastor-Ciurana J, Delgado-Morales R, Gómez-Román A, Carrasco J, Gagliano H, García-Gutiérrez MS, Manzanares J, Armario A.
    Eur Neuropsychopharmacol; 2015 Aug 28; 25(8):1248-59. PubMed ID: 26092203
    [Abstract] [Full Text] [Related]

  • 6. The role of endogenous cannabinoids in the hypothalamo-pituitary-adrenal axis regulation: in vivo and in vitro studies in CB1 receptor knockout mice.
    Barna I, Zelena D, Arszovszki AC, Ledent C.
    Life Sci; 2004 Oct 29; 75(24):2959-70. PubMed ID: 15454346
    [Abstract] [Full Text] [Related]

  • 7. The endogenous cannabinoid, anandamide, activates the hypothalamo-pituitary-adrenal axis in CB1 cannabinoid receptor knockout mice.
    Wenger T, Ledent C, Tramu G.
    Neuroendocrinology; 2003 Dec 29; 78(6):294-300. PubMed ID: 14688442
    [Abstract] [Full Text] [Related]

  • 8. Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function.
    Cota D, Steiner MA, Marsicano G, Cervino C, Herman JP, Grübler Y, Stalla J, Pasquali R, Lutz B, Stalla GK, Pagotto U.
    Endocrinology; 2007 Apr 29; 148(4):1574-81. PubMed ID: 17194743
    [Abstract] [Full Text] [Related]

  • 9. Cannabinoid Receptor Type 1 Agonist ACEA Improves Cognitive Deficit on STZ-Induced Neurotoxicity Through Apoptosis Pathway and NO Modulation.
    Crunfli F, Vrechi TA, Costa AP, Torrão AS.
    Neurotox Res; 2019 Apr 29; 35(3):516-529. PubMed ID: 30607903
    [Abstract] [Full Text] [Related]

  • 10. Increased Contextual Fear Conditioning in iNOS Knockout Mice: Additional Evidence for the Involvement of Nitric Oxide in Stress-Related Disorders and Contribution of the Endocannabinoid System.
    Lisboa SF, Gomes FV, Silva AL, Uliana DL, Camargo LH, Guimarães FS, Cunha FQ, Joca SR, Resstel LB.
    Int J Neuropsychopharmacol; 2015 Jan 24; 18(8):. PubMed ID: 25618404
    [Abstract] [Full Text] [Related]

  • 11. Remote CB1 receptor antagonist administration reveals multiple sites of tonic and phasic endocannabinoid neuroendocrine regulation.
    Newsom RJ, Garcia RJ, Stafford J, Osterlund C, O'Neill CE, Day HEW, Campeau S.
    Psychoneuroendocrinology; 2020 Mar 24; 113():104549. PubMed ID: 31884322
    [Abstract] [Full Text] [Related]

  • 12. Cytokines, prostaglandins and nitric oxide in the regulation of stress-response systems.
    Gądek-Michalska A, Tadeusz J, Rachwalska P, Bugajski J.
    Pharmacol Rep; 2013 Mar 24; 65(6):1655-62. PubMed ID: 24553014
    [Abstract] [Full Text] [Related]

  • 13. Characterization of the neuroprotective effect of the cannabinoid agonist WIN-55212 in an in vitro model of hypoxic-ischemic brain damage in newborn rats.
    Fernández-López D, Martínez-Orgado J, Nuñez E, Romero J, Lorenzo P, Moro MA, Lizasoain I.
    Pediatr Res; 2006 Aug 24; 60(2):169-73. PubMed ID: 16864698
    [Abstract] [Full Text] [Related]

  • 14. Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit.
    Ganon-Elazar E, Akirav I.
    Psychoneuroendocrinology; 2013 Sep 24; 38(9):1675-87. PubMed ID: 23433741
    [Abstract] [Full Text] [Related]

  • 15. Antidepressant--like properties of ACEA (arachidonyl-2-chloroethylamide), the selective agonist of CB1 receptors.
    Rutkowska M, Jachimczuk O.
    Acta Pol Pharm; 2004 Sep 24; 61(2):165-7. PubMed ID: 15493300
    [Abstract] [Full Text] [Related]

  • 16. Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis.
    Patel S, Roelke CT, Rademacher DJ, Cullinan WE, Hillard CJ.
    Endocrinology; 2004 Dec 24; 145(12):5431-8. PubMed ID: 15331569
    [Abstract] [Full Text] [Related]

  • 17. Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and 2.
    Rockwell CE, Snider NT, Thompson JT, Vanden Heuvel JP, Kaminski NE.
    Mol Pharmacol; 2006 Jul 24; 70(1):101-11. PubMed ID: 16611855
    [Abstract] [Full Text] [Related]

  • 18. Endocannabinoid signaling as an intrinsic component of the circuits mediating adaptive responses to repeated stress exposure in adult male sprague dawley rats.
    Newsom RJ, Stafford J, Garcia RJ, Campeau S.
    Stress; 2020 Mar 24; 23(2):174-189. PubMed ID: 31506004
    [Abstract] [Full Text] [Related]

  • 19. Arachidonyl-2'-chloroethylamide, a highly selective cannabinoid CB1 receptor agonist, enhances the anticonvulsant action of valproate in the mouse maximal electroshock-induced seizure model.
    Luszczki JJ, Czuczwar P, Cioczek-Czuczwar A, Czuczwar SJ.
    Eur J Pharmacol; 2006 Oct 10; 547(1-3):65-74. PubMed ID: 16930590
    [Abstract] [Full Text] [Related]

  • 20. [THE ROLE OF THE ENDOGENOUS CANNABINOID SYSTEM IN THE FORMATION OF THE GENERAL ADAPTATION SYNDROME].
    Krylatov AV, Serebrov VY.
    Ross Fiziol Zh Im I M Sechenova; 2016 Nov 10; 102(11):1265-79. PubMed ID: 30193444
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.